Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Caforio Appointed BMS CEO
Bristol-Myers Squibb (BMS) has named former chief operating officer Giovanni Caforio as the company’s new CEO.
Bristol-Myers Squibb (BMS) has named former chief operating officer Giovanni Caforio as the company’s new CEO, effective May 5. He will replace Lamberto Andreotti, who will become executive chairman of the board. Caforio has led transformational deals in BMS’s U.S. and global oncology departments. He has also served at the company as chief commercial officer and chief operating officer and has been a member of its senior management team since 2011.
Recent Videos
Related Content
